MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
STIM - Neuronetics Inc
$21.27
2.85(15.47%)9:00:00 PM 1/22/2021
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrist customers. Neuronetics, Inc. was founded in 2003 and is headquartered in Malvern, Pennsylvania.
Stock Chart

Summary:

  • Price Zscore is at a recent 2 week high. A recent high ZScore means price movement is accelerating at a record speed.
  • Volume Zscore is a recent 2 week high. A recent surge of ZScore means trading activities is accelerating at a record speed.
  • A moving average of Short volume ratio is at a recent 2 week high. A high short volume ratio indicate selling presures.
  • RSI is at a high level of 83. A high level of RSI indicates the stock is overbought.
  • MACD is crossing MACD signal line at 0.8. MACD crossing signal line is bullish signal.

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Related Topics
leak data

Related Topics

Peers

Related Peers

Stock news

    01/19/2021STIM
    NeuroStar® Advanced Therapy’s Depression Outcomes Registry Hits 10,000 Patient Milestone

    World’s largest Major Depressive Disorder registry results validate real-world outcomes; majority experience significant improvementMALVERN, Pa., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced its NeuroStar® Advanced Therapy Outcomes Registry, the largest outcomes registry in...

    01/14/2021STIM
    What Type Of Shareholders Make Up Neuronetics, Inc.'s (NASDAQ:STIM) Share Registry?

    A look at the shareholders of Neuronetics, Inc. ( NASDAQ:STIM ) can tell us which group is most powerful. Institutions...

    01/12/2021STIM
    Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2020 Financial Results

    MALVERN, Pa., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today, in advance of the ICR/Westwicke Conference, announced certain preliminary unaudited fourth quarter and full year 2020 revenue results. Fourth Quarter 2020 * Fourth quarter 2020 preliminary unaudited revenue between $15.0 a...

    01/11/2021STIM
    Neuronetics (STIM) in Focus: Stock Moves 6.8% Higher

    Neuronetics (STIM) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

    01/7/2021STIM
    Neuronetics to Participate at the 23rd Annual ICR Westwicke Conference

    MALVERN, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that Keith Sullivan, President and Chief Executive Officer, and Steve Furlong, Chief Financial Officer, will be presenting at the 23rd Annual ICR Westwicke Conference, and participating in a panel discussion on Thur...

    01/7/2021STIM
    Neuronetics Announces Expansion of Sales Organization

    MALVERN, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced the expansion of its commercial organization. Sales Organization Update As part of the Company’s previously announced sales organization optimization initiative, the Company recently expanded the size of its sales...

    12/15/2020STIM
    Is STIM A Good Stock To Buy Now?

    Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that’s why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an […]

    12/8/2020STIM
    Neuronetics Announces the Amendment of Credit Facility with Solar Capital Partners

    Amendment provides Neuronetics with available and flexible funding options through 2022MALVERN, Pa., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced it has amended its term loan agreement with its current lenders, investment affiliates managed by Solar Capital Partners, LLC (S...